Lataa...
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in post-menopausal patients with breast cancer
Discovery of clinical and genetic predictors of exemestane pharmacokinetics was attempted in 246 post-menopausal patients with breast cancer enrolled on a prospective clinical study. A sample was collected two hours after exemestane dosing at a 1 or 3 month study visit to measure drug concentration....
Tallennettuna:
| Julkaisussa: | Pharmacogenomics J |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323433/ https://ncbi.nlm.nih.gov/pubmed/27549341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2016.60 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|